Thomas Gerald Beach
#123,761
Most Influential Person Now
Thomas Gerald Beach's AcademicInfluence.com Rankings
Thomas Gerald Beachmedical Degrees
Medical
#1933
World Rank
#2320
Historical Rank
Neurology
#186
World Rank
#259
Historical Rank

Download Badge
Medical
Thomas Gerald Beach's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Thomas Gerald Beach Influential?
(Suggest an Edit or Addition)Thomas Gerald Beach's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012) (2093)
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2011) (1839)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) (1494)
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease (1999) (1427)
- Analysis of shared heritability in common disorders of the brain (2016) (1385)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Primary age-related tauopathy (PART): a common pathology associated with human aging (2014) (988)
- Use of florbetapir-PET for imaging beta-amyloid pathology. (2011) (938)
- Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. (2013) (866)
- Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. (1999) (802)
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) (793)
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders (2010) (739)
- Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease (2003) (721)
- PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease (2010) (699)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (2012) (652)
- Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. (2006) (539)
- A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. (2007) (521)
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (2009) (510)
- Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons (2008) (486)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020) (463)
- Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients (2004) (457)
- GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers (2007) (452)
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. (2020) (444)
- Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism (2001) (416)
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study (2015) (374)
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2019) (372)
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease (2014) (363)
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
- PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. (2007) (318)
- Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease (2009) (308)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Patterns of gliosis in alzheimer's disease and aging cerebrum (1989) (307)
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. (2013) (307)
- Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology (2014) (303)
- GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. (2007) (277)
- Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease (2003) (274)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program (2015) (265)
- Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. (2008) (258)
- Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. (2004) (256)
- Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* (2001) (254)
- Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. (2007) (247)
- Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease (2003) (246)
- Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. (2015) (238)
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study (2013) (235)
- The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007 (2007) (234)
- Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† (2002) (233)
- Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles (2006) (222)
- Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production (2008) (219)
- Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative (2007) (218)
- Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review (2015) (209)
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. (2012) (208)
- Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression (2020) (207)
- Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. (2006) (195)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients (2003) (190)
- Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects (2006) (188)
- Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy (2001) (187)
- SNAP-25 deficit and hippocampal connectivity in schizophrenia. (1998) (186)
- Pathologic findings in prospectively ascertained essential tremor subjects (2008) (179)
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. (2020) (174)
- Use of Florbetapir-PET for Imaging-Amyloid Pathology (2011) (172)
- Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss (2012) (163)
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
- Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease (2010) (162)
- Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders (2008) (162)
- Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology (2009) (160)
- Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease (2004) (160)
- Gene expression correlates of neurofibrillary tangles in Alzheimer's disease (2006) (159)
- Cerebral blood flow in Alzheimer’s disease (2012) (157)
- Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. (2007) (157)
- Evaluation of α-synuclein immunohistochemical methods used by invited experts (2008) (155)
- Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes (2015) (154)
- Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation (2020) (154)
- Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia (2001) (151)
- Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy (1995) (149)
- Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies (2015) (145)
- Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease (2012) (144)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease (2000) (140)
- Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. (2008) (139)
- Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism (2000) (138)
- Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. (2002) (138)
- Does Parkinson’s disease start in the gut? (2017) (137)
- Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene. (2010) (136)
- Atherosclerosis of Cerebral Arteries in Alzheimer Disease (2004) (134)
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease (2015) (131)
- TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014) (127)
- The distribution of substance P in the primate basal ganglia: An immunohistochemical study of baboon and human brain (1984) (125)
- Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center (2005) (123)
- Postmortem interval effect on RNA and gene expression in human brain tissue (2011) (120)
- 3‐hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis (2013) (120)
- microRNA Profiles in Parkinson's Disease Prefrontal Cortex (2016) (119)
- Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry (2014) (117)
- Frequency of Alzheimer’s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus (2011) (116)
- Parkinson disease affects peripheral sensory nerves in the pharynx. (2013) (116)
- Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With A&bgr; Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue (2012) (115)
- Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes (2017) (114)
- Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology (2016) (112)
- Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains (2013) (111)
- [18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology (2015) (110)
- Alzheimer's disease a century later. (2006) (110)
- Altered Pharyngeal Muscles in Parkinson Disease (2012) (109)
- Reduced striatal tyrosine hydroxylase in incidental Lewy body disease (2008) (107)
- Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) (106)
- Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease (2011) (105)
- Evidence for an association between KIBRA and late-onset Alzheimer's disease (2010) (105)
- Concomitant pathologies among a spectrum of parkinsonian disorders. (2014) (104)
- Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex (1988) (103)
- Submandibular gland needle biopsy for the diagnosis of Parkinson disease (2014) (103)
- Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis (2021) (103)
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects (2014) (102)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. (2013) (99)
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease (2018) (98)
- Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity (2018) (98)
- Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. (2011) (97)
- Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease (2014) (97)
- Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. (2007) (96)
- Submandibular gland biopsy for the diagnosis of Parkinson disease. (2013) (95)
- Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease (2015) (91)
- In vitro high affinity α-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1 (2008) (89)
- Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia (2009) (88)
- The history of Alzheimer's disease: three debates. (1987) (86)
- Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains. (2004) (85)
- Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity (2014) (85)
- Amyloid load in nondemented brains correlates with APOE e4 (2010) (85)
- C9ORF72 repeat expansions in cases with previously identified pathogenic mutations (2013) (85)
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies (2013) (83)
- Parkinson disease and incidental Lewy body disease (2015) (83)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- Diagnosis of prostate cancer using differentially expressed genes in stroma. (2010) (83)
- Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers (2014) (82)
- Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease (2011) (81)
- Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level (2021) (80)
- Sorl1 as an Alzheimer’s Disease Predisposition Gene? (2007) (78)
- Essential tremor is not associated with cerebellar Purkinje cell loss (2014) (78)
- Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology. (2011) (77)
- Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease? (1997) (77)
- Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation (1987) (76)
- Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits (2007) (75)
- Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment (2010) (75)
- Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection (2016) (75)
- An animal model of prophylactic cranial irradiation: histologic effects at acute, early and delayed stages. (1990) (74)
- Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (73)
- TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies (2013) (73)
- Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology (2010) (73)
- Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex (2015) (73)
- Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease (2019) (72)
- Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation (2012) (72)
- Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. (2000) (71)
- Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD. (2010) (71)
- Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. (2015) (71)
- Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease (2009) (70)
- Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging (2011) (69)
- APP/Aβ structural diversity and Alzheimer's disease pathogenesis (2017) (69)
- Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. (2011) (68)
- Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease (1998) (68)
- Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (67)
- The Search for a Peripheral Biopsy Indicator of &agr;-Synuclein Pathology for Parkinson Disease (2017) (67)
- Graph theory network function in Parkinson’s disease assessed with electroencephalography (2016) (67)
- Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition (2000) (67)
- Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database (2013) (67)
- Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains (2020) (66)
- Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease. (2014) (64)
- Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition (2016) (64)
- Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists (2001) (64)
- JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells. (2016) (63)
- Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging. (2012) (63)
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
- Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects (2012) (63)
- Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (62)
- Soluble Amyloid b Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease (1999) (61)
- Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. (2016) (61)
- Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies (2012) (61)
- Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. (2006) (61)
- Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients (2020) (60)
- Systematic Optimization of Long Gradient Chromatography Mass Spectrometry for Deep Analysis of Brain Proteome (2014) (60)
- Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies (2016) (60)
- Increased CSF biomarkers of angiogenesis in Parkinson disease (2015) (59)
- Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease (2017) (59)
- Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease (2006) (59)
- Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. (2014) (59)
- Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) (59)
- Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings (2016) (59)
- Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations (2008) (58)
- Chemical phenotype of calretinin interneurons in the human striatum (1998) (57)
- Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease (2021) (57)
- Importance of low diagnostic Accuracy for early Parkinson's disease (2018) (56)
- The Evolution of Aβ Peptide Burden in the APP23 Transgenic Mice: Implications for Aβ Deposition in Alzheimer Disease (2001) (55)
- Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers (2004) (54)
- Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease. (2011) (53)
- Do cholinergic therapies have disease-modifying effects in Alzheimer’s disease? (2006) (52)
- Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. (2011) (52)
- Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease (2014) (52)
- Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. (2013) (52)
- Alzheimer Disease: Scientific Breakthroughs and Translational Challenges (2017) (51)
- Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease (2018) (50)
- In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease (2020) (50)
- Essential tremor and Parkinson's disease: Lack of a link (2011) (50)
- Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease (2021) (49)
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau (2021) (49)
- Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease. (2012) (49)
- Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition (2000) (49)
- Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders. (2016) (48)
- Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer's brain (2018) (48)
- PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease (2015) (48)
- Brain proteome-wide association study implicates novel proteins in depression pathogenesis (2021) (48)
- Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies (2016) (47)
- Expression and Localization of Mitochondrial Ferritin mRNA in Alzheimer's Disease Cerebral Cortex (2011) (47)
- Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease. (2015) (46)
- Effect of ApoE isoforms on mitochondria in Alzheimer disease (2020) (45)
- Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition. (2018) (45)
- Increased expression of the urokinase plasminogen-activator receptor in amyloid β peptide-treated human brain microglia and in AD brains (2002) (45)
- The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease. (2017) (44)
- 27-plex Tandem Mass Tag Mass Spectrometry for Profiling Brain Proteome in Alzheimer's Disease. (2020) (44)
- The biochemical aftermath of anti-amyloid immunotherapy (2010) (43)
- Simplified conversion method for unified Parkinson's disease rating scale motor examinations (2015) (43)
- Impaired hepatic amyloid-beta degradation in Alzheimer’s disease (2018) (43)
- Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease (2018) (43)
- Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations (2013) (43)
- Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia? (2009) (42)
- Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors. (2002) (42)
- Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non-human primates. (1995) (42)
- Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue (2016) (42)
- Small‐Amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations (2002) (41)
- Light microscopic evidence for a substance P-containing innervation of the human nucleus basalis of Meynert (1987) (41)
- Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis (2013) (41)
- The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease. (2016) (40)
- Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? (2011) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program (2016) (40)
- Calretinin-immunoreactive neurons in the human striatum (1995) (39)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes. (2019) (38)
- MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy (2017) (37)
- Neurochemical profile of dementia pugilistica. (2013) (37)
- Revealing the brain's molecular architecture. (2018) (37)
- Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome (2015) (36)
- Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases (1998) (36)
- Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine (2001) (35)
- Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging. (2019) (35)
- Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment (2015) (35)
- TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. (2007) (34)
- Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging. (2012) (34)
- Patients With Alzheimer Disease Have Altered Transmitral Flow (2009) (34)
- Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations. (2014) (34)
- Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition (2018) (34)
- Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. (2014) (34)
- Correlation of Clinical Features With Argyrophilic Grains at Autopsy (2009) (33)
- Pathology in essential tremor. (2012) (33)
- The distribution of phosphorylated tau in spinal cords of Alzheimer's disease and non-demented individuals. (2013) (33)
- Evaluation of Parkinson Disease Risk Variants as Expression-QTLs (2012) (33)
- A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley? (2017) (33)
- Progressive Aphasia with Lewy Bodies (2002) (33)
- Infiltration of T Lymphocytes and Expression of ICAM-1 in the Hippocampus of Patients with Hippocampal Sclerosis (2010) (33)
- Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects. (2009) (32)
- Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson’s Disease Patients (2015) (32)
- Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease (2009) (32)
- Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease (2018) (32)
- Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients (2009) (31)
- Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy (2013) (31)
- Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations (1998) (31)
- Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure (2021) (31)
- Neocortical substance P neurons in the baboon: An immunohistochemical finding (1983) (30)
- Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression (2018) (30)
- Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease (2020) (30)
- Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism (2020) (30)
- Altered APP Processing in PDAPP (Val717 → Phe) Transgenic Mice Yields Extended-Length Aβ Peptides. (2005) (29)
- Presenilin-1 280Glu→Ala Mutation Alters C-Terminal APP Processing Yielding Longer Aβ Peptides: Implications for Alzheimer’s Disease (2008) (29)
- Amyloidogenic Medin Induces Endothelial Dysfunction and Vascular Inflammation Through the Receptor for Advanced Glycation Endproducts (2017) (29)
- Autonomic complaints in patients with restless legs syndrome. (2013) (28)
- Theoretical Impact of Florbetapir (18F) Amyloid Imaging on Diagnosis of Alzheimer Dementia and Detection of Preclinical Cortical Amyloid (2014) (28)
- GBA mutations in Parkinson disease: earlier death but similar neuropathological features (2017) (28)
- Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy. (2008) (28)
- Induction of pluripotent stem cells from autopsy donor-derived somatic cells (2011) (28)
- Alzheimer’s patient brain myeloid cells exhibit enhanced aging and unique transcriptional activation (2019) (28)
- Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4) (2018) (27)
- Thiorphan-induced neprilysin inhibition raises amyloid β levels in rabbit cortex and cerebrospinal fluid (2003) (27)
- Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology (2019) (27)
- The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target (2018) (27)
- Physiologic Origins of Age-Related β-Amyloid Deposition (2008) (26)
- Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation (2017) (26)
- Senile plaques, amyloid β-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex (2004) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Cortical cholinergic denervation elicits vascular A beta deposition. (2000) (26)
- Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology (2017) (26)
- Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study (2018) (25)
- Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia (2019) (25)
- Next-generation profiling to identify the molecular etiology of Parkinson dementia (2016) (25)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
- Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. (2020) (25)
- Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
- An association with great implications: vascular pathology and Alzheimer disease. (2006) (24)
- Tau immunoreactivity in peripheral tissues of human aging and select tauopathies (2019) (24)
- The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease (2013) (24)
- Alzheimer's disease and the "Valley Of Death": not enough guidance from human brain tissue? (2012) (23)
- TMEM106B haplotypes have distinct gene expression patterns in aged brain (2018) (23)
- In vitro-differentiated neural cell cultures progress towards donor-identical brain tissue. (2013) (23)
- Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases (2016) (23)
- A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor (2017) (23)
- Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient. (2011) (23)
- Alzheimer’s Disease Research Using Human Microglia (2019) (22)
- Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels (2022) (22)
- Altered APP processing in PDAPP (Val717 --> Phe) transgenic mice yields extended-length Abeta peptides. (2005) (22)
- Identification of Circular RNAs using RNA Sequencing. (2019) (21)
- Cholinergic fiber loss occurs in the absence of synaptophysin depletion in Alzheimer's disease primary visual cortex (1992) (21)
- Vagus Nerve and Stomach Synucleinopathy in Parkinson Disease, Incidental Lewy Body Disease and Normal Elderly Subjects: Evidence Against the Body-First Hypothesis (2020) (21)
- A single cell-based atlas of human microglial states reveals associations with neurological disorders and histopathological features of the aging brain (2018) (21)
- Genetic analysis of α-synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies (2017) (21)
- Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia (2019) (20)
- Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study (2021) (20)
- Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease (2003) (20)
- Alzheimer’s Disease Neuropathological Comorbidities Are Common in the Younger-Old (2020) (20)
- Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions. (2014) (20)
- Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study (2020) (19)
- A case study of temporal lobe development in familial schizophrenia (1996) (19)
- Correlation of the Expression Level of C1q mRNA and the Number of C1q-Positive Plaques in the Alzheimer Disease Temporal Cortex (2001) (19)
- Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer’s Disease: Analysis of 13 Cases (2016) (19)
- Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression (2020) (18)
- Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer’s Disease (2016) (18)
- Intracranial Atherosclerosis as a contributing factor to Alzheimer's disease Dementia (2009) (18)
- Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway (2017) (18)
- Phosphorylated TDP-43 in frontotemporal lobar degeneration and ALS (2009) (18)
- Bid signal pathway components are identified in the temporal cortex with Parkinson disease (2012) (18)
- Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease (2019) (18)
- Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease (2020) (17)
- Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls. (2021) (17)
- The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane (2016) (17)
- Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease. (2011) (17)
- Tract-tracing with horseradish peroxidase in the postmortem human brain (1987) (17)
- Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. (2018) (17)
- A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
- Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease (2011) (16)
- Assessment of APOE in atypical parkinsonism syndromes (2019) (16)
- Alpha-synuclein: prion or prion-like? (2019) (15)
- Essential Tremor in the Elderly and Risk for Dementia (2014) (15)
- Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations. (2013) (15)
- Ventral striatal D3 receptors and Parkinson's Disease (2001) (15)
- Increased β-amyloid precursor protein mRNA in the rat cerebral cortex and hippocampus after chronic systemic atropine treatment (1996) (15)
- [18F]FLUTEMETAMOL AMYLOID PET IN SYMPTOMATIC ALZHEIMER'S DISEASE (AD) AND PATHOLOGICALLY PRECLINICAL AD (P-PREAD) IN COMPARISON TO NON-AD CONTROLS: IMPACT OF CEREBRAL AMYLOID ANGIOPATHY (2014) (15)
- Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (2018) (14)
- Lamina-selective A68 immunoreactivity in primary visual cortex of Alzheimer's disease patients (1989) (14)
- Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease (2014) (14)
- The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology (2003) (14)
- Myoclonus in Lewy body disorders. (2002) (14)
- SMG1 Identified as a Regulator of Parkinson’s Disease-Associated alpha-Synuclein through siRNA Screening (2013) (14)
- A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease (2020) (14)
- A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases (2016) (13)
- Muscarinic agonists as preventative therapy for Alzheimer's disease. (2002) (13)
- Deep Profiling of Microgram-Scale Proteome by Tandem Mass Tag Mass Spectrometry. (2020) (13)
- Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease (2017) (13)
- Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
- Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets (2020) (13)
- Incidental Lewy body disease: Electrophysiological findings suggesting pre-clinical Lewy body disorders (2011) (12)
- Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR. (2012) (12)
- Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways (2019) (12)
- Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes (2020) (12)
- Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy (2014) (12)
- Multicentre phase 3 trial on florbetaben for beta-amyloid brain PET in Alzheimer's disease (2012) (12)
- Association of AEBP1 and NRN1 RNA expression with Alzheimer’s disease and neurofibrillary tangle density in middle temporal gyrus (2019) (12)
- Sirtuin 3 Mediates Tau Deacetylation. (2019) (12)
- Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease. (2019) (11)
- Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease. (2019) (11)
- Featured Articles National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012) (11)
- Nanoliposomes protect against human arteriole endothelial dysfunction induced by β-amyloid peptide (2016) (11)
- Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat. (2014) (11)
- Calretinin gene expression in the human thalamus. (1998) (11)
- Retrograde filling of pyramidal neurons in postmortem human cerebral cortex using horseradish peroxidase (1988) (11)
- Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin (2019) (11)
- Spatially resolved transcriptomics reveals unique gene signatures associated with human temporal cortical architecture and Alzheimer’s pathology (2021) (10)
- Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype (2017) (10)
- Phase III trial results for the amyoid PET imaging agent Florbetapir F 18 (18F-AV-45): imaging to histopathologic correlations in an end-of-life human subject study (2010) (10)
- Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies (2021) (10)
- Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology (2013) (10)
- Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment (2020) (10)
- Genome-wide association study and functional validation implicates JADE1 in tauopathy (2021) (10)
- Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab. (2016) (10)
- Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease. (2021) (9)
- The Impact of Aging on Brain Pituitary Adenylate Cyclase Activating Polypeptide, Pathology and Cognition in Mice and Rhesus Macaques (2017) (9)
- BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains. (2013) (9)
- Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia (2022) (9)
- Ventral striatal D(3) receptors and Parkinson's Disease. (2001) (9)
- Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients (2015) (9)
- Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases (2015) (9)
- Differential expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin-immunoreactive neurons in the human striatum (1999) (9)
- Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia (2020) (8)
- Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence (2022) (8)
- Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. (2010) (8)
- Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains (2021) (8)
- Short Elevated A b 42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of A b PP Metabolism (2000) (8)
- Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings (2017) (8)
- Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40. (2018) (8)
- Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia. (2018) (8)
- Assessment of persistent, bioaccumulative and toxic organic environmental pollutants in liver and adipose tissue of Alzheimer's disease patients and age- matched controls. (2019) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium (2021) (7)
- Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report. (2020) (7)
- Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19 (2021) (7)
- Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease: An Updated Clinicopathologic Study. (2020) (6)
- Variability of diffuse plaques and amyloid angiopathy in Parkinson’s disease with mild cognitive impairment (2010) (6)
- Interpretable deep learning of myelin histopathology in age-related cognitive impairment (2022) (6)
- Prevalence of REM sleep behavior disorder in Sun City, Arizona (2020) (6)
- A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies (2021) (6)
- Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168 (2017) (6)
- Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease (2021) (6)
- Acute Brain Ischemia, Infarction and Hemorrhage in Subjects Dying with or Without Autopsy-Proven Acute Pneumonia (2021) (5)
- Disassembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients (2009) (5)
- Sirtuin 3 is down-regulated in Apolipoprotein E4 carriers with Alzheimer’s disease (P5.011) (2015) (5)
- Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness (2021) (5)
- The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease. (2016) (5)
- Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients (2021) (5)
- Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease (2018) (5)
- ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer’s disease (2020) (4)
- Hippocampal synaptic pathology in patients with temporal lobe epilepsy (1994) (4)
- Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body disease (2020) (4)
- Contrast Acuity With Different Colors in Parkinson's Disease (2019) (4)
- NEUROFIBRILLARY TANGLE PREDOMINANT DEMENTIA: CLINICAL AND PATHOLOGICAL DESCRIPTION IN A CASE SERIES (2016) (4)
- Effect of olfactory bulb pathology on olfactory function in normal aging (2022) (4)
- Featured Articles Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease (2009) (4)
- Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy (2021) (4)
- Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease (2021) (4)
- Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease (2018) (4)
- O4-03-06 Cortical cholinergic deficit is associated with plaque development at preclinical stages of Alzheimer's disease (2004) (4)
- 2.13.1 PATHOLOGY IN ESSENTIAL TREMOR (2012) (4)
- Role of Astrocyte Dysfunction in Epilepsy (2009) (4)
- Erratum to: Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue (2016) (3)
- Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson's Disease1. (2019) (3)
- Correction: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology (2014) (3)
- [Significance of the TDP-43 deposition in FTLD-U and ALS]. (2008) (3)
- A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk. (2021) (3)
- Florbetapir (18F-AV-45) PET imaging of {beta}-amyloid plaques is highly correlated with histopathological assays at autopsy (2010) (3)
- Phospho‐tau217 and phospho‐tau181 in plasma and CSF as biomarkers for Alzheimer’s disease (2020) (3)
- Neurofibrillary Tangle Predominant Dementia: Clinical andPathological Description in a Case Series (2016) (3)
- Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (2)
- Clinicopathologic Correlations in 172 Cases of REM Sleep Behavior Disorder ± a Coexisting Neurologic Disorder (PL01.003) (2013) (2)
- Microglial and Astrocytic Reactions in Alzheimer’s Disease (2002) (2)
- Correlation Between the Movement Disorder Society's Unified Parkinson's Disease Rating Scale and Nonmotor Scales in Patients with Parkinson's Disease. (2019) (2)
- Neuroimagenomics for the Study of Human Obesity (2006) (2)
- Echocardiography vortex formation time reveal cardiac diastolic transmitral flow dysfunction in Alzheimer's disease patients (2009) (2)
- White Matter Beta-Amyloid Precursor Protein Immunoreactivity in Autopsied Subjects With and Without COVID-19 (2021) (2)
- Morphological and biochemical analysis of the 3xTg-Alzheimer's disease mouse model: Implications for sporadic Alzheimer's disease and the amyloid cascade hypothesis (2011) (2)
- COMPARISON OF REGIONAL FLORTAUCIPIR PET TO QUANTITATIVE TAU AND AMYLOID IMMUNOASSAY IN PATIENTS WITH ALZHEIMER’S DISEASE PATHOLOGY: A PILOT CLINICO-PATHOLOGICAL STUDY (2017) (2)
- An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson’s Disease (2021) (2)
- CHANGES IN TAU PROTEIN LANDSCAPE DURING ALZHEIMER’S DISEASE PROGRESSION (2017) (2)
- Characteristics of people misdiagnosed with Alzheimer's disease and their medication use: An analysis of the National Alzheimer's Coordinating Center Uniform Data Set database (2013) (2)
- Clonal Evolution of a Case of Treatment Refractory Maxillary Sinus Carcinoma (2012) (2)
- A Modification of the Bielschowsky Silver Stain for Alzheimer Neuritic Plaques: Suppression of Artifactual Staining by Pretreatment with Oxidizing Agents (2019) (2)
- A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3 (2021) (2)
- Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease (2018) (1)
- Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer’s Disease (2023) (1)
- Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate? (2020) (1)
- Detection of beta-Amyloid by Florbetaben PET: Histopathological Verification in a Global Phase 3 Clinical Trial (2012) (1)
- Salivary Gland Biopsy as a Diagnostic Test for Parkinson's Disease (IN2-1.002) (2013) (1)
- HETEROGENEITY IN TAU, AMYLOID AND CO-MORBID PATHOLOGIES IN ALZHEIMER'S DISEASE (2017) (1)
- Comparison of florbetapir-PET scans to postmortem beta-amyloid histopathology in 59 autopsy cases (2012) (1)
- Alterations of the Sensory and Cognitive Components of Operative Memory in a Monkey Model of Alzheimer's Disease (2003) (1)
- Decreased Levels of Beta‐Arrestin 1 in Brains of Patients with Alzheimer's Disease (2018) (1)
- Expression and localization of lactotransferrin mRNA in the cortex of Alzheimer’s disease (2009) (1)
- ACValidator: A novel assembly-based approach for in silico verification of circular RNAs (2020) (1)
- Further methodological problems in cell counting (1987) (1)
- brain human functionally distinct regions of the normal aged Gene expression profiles in anatomically and (2015) (1)
- ACValidator: a novel assembly-based approach for in silico validation of circular RNAs (2019) (1)
- Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease. (2021) (1)
- THE HUMAN BRAINOME: HUMAN BRAIN GENOME, TRANSCRIPTOME, AND PROTEOME INTEGRATION (2016) (1)
- Abstract 2187: A rapid autopsy program for cancer research (2018) (1)
- Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease? (2018) (1)
- Diagnostic value of [18F]flutemetamol amyloid PET: comparison between imaging and neuropathology (2014) (1)
- Response to Parkinnen et al. and Jellinger (2009) (1)
- Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research (2020) (1)
- TEMPORAL LOBE QUANTITATION OF FLORTAUCIPIR PET IMAGES MAY IMPROVE DETECTION OF INTERMEDIATE NEUROFIBRILLARY TANGLE PATHOLOGY IN AUTOPSY-VALIDATED CASES (2019) (1)
- Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology (2015) (1)
- Clinical and Neuropathological Correlates of Visual Hallucinations in Parkinsonism (2013) (1)
- Hemispheric asymmetry and atypical lobar progression of Alzheimer‐type tauopathy (2022) (1)
- Impaired Processes of Working Memory in the Monkey Model of Alzheimer's Disease (2002) (1)
- Profiling the NOTCH2NLC GGC Repeat Expansion in Parkinson's Disease in the European Population (2022) (1)
- Deep multilayer brain proteomics identifies molecular networks and Netrin‐1 accumulation in Alzheimer’s disease progression (2020) (1)
- Heart rate variability as a screening tool for Parkinson’s disease has age-dependent performance (P1.110) (2017) (1)
- INCREASED EXPRESSION OF TOLL-LIKE RECEPTOR (TLR)-3 IN ALZHEIMER’S DISEASE BRAINS: A PROTECTIVE OR PATHOGENIC RESPONSE? (2017) (1)
- Lewy bodies are incidental in essential tremor. (2016) (1)
- Tg-SwDI Transgenic Mice Exhibit Novel Alterations in A (cid:1) PP Processing, A (cid:1) Degradation, and Resilient Amyloid Angiopathy (2008) (1)
- Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau (2020) (1)
- Deficiency of WFS1 increases vulnerability to pathological tau in vitro and in vivo (2020) (1)
- Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies. (2021) (1)
- Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment (2022) (1)
- Faculty Opinions recommendation of Solvent exposures and Parkinson disease risk in twins. (2012) (0)
- Amyloid Imaging with Florbetapir F 18 (18F-AV-45) PET in a subject with Down's Syndrome and Alzheimer's disease at the End of Life (2010) (0)
- Is there an increased risk of death from natural causes in young adult apolipoprotein E epsilon 4 carriers? (2010) (0)
- Differential expression of tumor necrosis factor (TNF) α between the temporal and cerebellar cortices of people with Alzheimer's disease compared with alterations in TNF receptor expression (2013) (0)
- APOE4 NON-CARRIERS WITH THE CLINICAL DIAGNOSIS OF ALZHEIMER'S DEMENTIA AND MINIMAL AMYLOID HISTOPATHOLOGY (2014) (0)
- Selective deafferentation of the rabbit cortex: A new animal model of Alzheimer's disease (2000) (0)
- Alzheimer's disease subjects carrying the APOE4 allele have lower brain BACE1 levels than APOE3 carriers (2011) (0)
- Comparison of clinical and neuropathological definitions of alzheimer's disease at national institute on aging Alzheimer's disease centers, 2005-2010 (2011) (0)
- P1-474: Membrane bound Aβ peptides in Alzheimer's disease and nondemented subjects (2008) (0)
- PT581. Multiple accumulation of neurodegenerative disease-related proteins in familial granulin mutation brains (2016) (0)
- Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study (2022) (0)
- Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation. (2021) (0)
- P3-256 Mechanism of neurofibrillary tangle-induced neuronal degeneration leading to Ad (2004) (0)
- Metabolic profiling of neocortical tissue discriminates Alzheimer’s disease from mild cognitive impairment, high pathology controls, and normal controls (2020) (0)
- Inflammatory Mechanisms in Alzheimer'S Disease and Other Neurodegenerative Disorders (2008) (0)
- Is beta‐arrestin related to muscarinic receptor uncoupling in Alzheimer's disease? (153.4) (2014) (0)
- Polygenic risk scores can predict AD‐related pathologies (2020) (0)
- PACAP Deficit in Alzheimer's Disease and Protection Against Beta-Amyloid Toxicity (I11-1.010) (2014) (0)
- receptors and the PI3K-Akt pathway in the case of galantamine and donepezil but not for rivastigmine. P4-296 AMYLOID- PEPTIDE REMNANTS IN AN-1792- IMMUNIZED ALZHEIMER’S DISEASE PATIENTS (2006) (0)
- JAMA Neurology Peer Reviewers in 2016. (2017) (0)
- P3-275 Expression and regulation of inflammatory genes in human brain endothelial cells induced by beta-amyloid peptides (2006) (0)
- Abstract 18245: Palmitic Acid-induced Endothelial Dysfunction in Human Leptomeningeal and Adipose Arterioles (2015) (0)
- IMMUNOPHENOTYPING OF MICROGLIA: CHARACTERIZATION OF A VARIANT OF CD105 AS A MARKER OF ACTIVATED MICROGLIA IN ALZHEIMER’S DISEASE AND AGED BRAINS (2019) (0)
- miRNA Biomarker Identification Using a Sequencing-Based Nuclease Protection Assay (NPSeq™) (2013) (0)
- Cortical Cholinergic Deafferentation Induces Aβ Deposition (2005) (0)
- Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia (2020) (0)
- THE DISTINCT CONTRIBUTION OF SNCA-3′UTR TO PARKINSON’S AND DEMENTIA WITH LEWY BODIES (2017) (0)
- [Frontotemporal dementia (FTD) and genetic mutations including progranulin gene]. (2008) (0)
- Toronto: HAI Amyloid Imaging Conference Abstracts This concludes a six-part series of the HAI Amyloid Imaging Conference. See also (2010) (0)
- FUNCTIONAL, GLOBAL, AND COGNITIVE DECLINE CORRELATES TO ACCUMULATION OF ALZHEIMERʼS PATHOLOGY.: 9. (2006) (0)
- Neuropathological outcome of prospectively followed normal elderly brain bank volunteers (2013) (0)
- Neural Cell Degeneration in Human Retinas May Explain Visual Dysfunction in Parkinson Disease (2017) (0)
- Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology (2019) (0)
- An immunohistochemical study of the substance P neuronal system in the primate brain : basal ganglia and neocortex (1984) (0)
- Repeat Submandibular Gland Biopsies as a Progression Marker in Parkinson’s Disease (S10.002) (2019) (0)
- HUMAN CHOROID PLEXUS INFLAMMATORY FEATURES: A STUDY IN POSTMORTEM CHOROID PLEXUS TISSUES AND EPITHELIAL CELLS (2018) (0)
- Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
- Color vision and contrast sensitivity in Parkinson Disease (P1.041) (2018) (0)
- Biochemical consequences of traumatic brain injury in dementia pugilistica (2012) (0)
- Clinicopathological Correlates of Verbal Fluency in Parkinson’s Disease: A Pilot Study (P3.197) (2018) (0)
- 111 Hippocampal presynaptic proteins in schizophrenia (1997) (0)
- Abstract 380: Impairment of Human Microvascular Function Induced by β-amyloid and Cardiovascular Risk Factors (2016) (0)
- Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies (2013) (0)
- Endothelial Dysfunction in Leptomeningeal and Peripheral Arterioles Induced by beta-amyloid Peptides: A Novel Human Model to Study Alzheimer's Disease (2013) (0)
- A b structural diversity and Alzheimer ' s disease pathogenesis (2017) (0)
- Spatially Resolved Transcriptomics Reveals Gene Signatures Underlying the Vulnerability of Human Middle Temporal Gyrus in Alzheimer's Disease (2021) (0)
- Abstract 2735: Diagnosis of prostate cancer without tumor cells using differentially expressed genes in the tumor microenvironment (2010) (0)
- Carotid artery stenosis as a risk factor for Alzheimer’s disease (2020) (0)
- Risk of Developing Dementia in Essential Tremor (S53.004) (2013) (0)
- Correlation of cerebrospinal fluid cytokines with cortical microglia densities in clinicopathological Alzheimer's disease and cognitively normal individuals (2012) (0)
- Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression (2018) (0)
- Abstract TMP96: Determining the Relationship Between Cognitive Function and ex-vivo Leptomeningeal Arteriole Function: A Study in Rapid Autopsy Brain Donors (2018) (0)
- Alzheimer's disease and the Valley of Death: Not enough guidance from human brain tissue? (2012) (0)
- P2-168 Can neuropathological and nicotinic receptor binding differences distinguish mild cognitive impairment from Alzheimer’s disease and normal aging? (2006) (0)
- The interaction of beta-amyloid with alpha1-chimaerin involved in the pathogenesis of Alzheimer's disease (2011) (0)
- Prevalence Of Lewy-Type Synucleinopathy In The Submandibular Gland Of Subjects With Neuropathologically-Confirmed Dementia With Lewy Bodies. (S38.007) (2014) (0)
- P4-296 Amyloid-β peptide remnants in AN-1792-immunized Alzheimer’s disease patients (2006) (0)
- Abstract 14270: Medin Amyloid, but Not β-amyloid, Induces Pro-Inflammatory Signaling in Endothelial Cells That is Synergistic With Palmitic Acid (2017) (0)
- Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4 (2021) (0)
- Reliable Detection Of Striatal Amyloid With [18F] Flutemetamol: Validation With Postmortem Histopathology (P6.328) (2014) (0)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal dementia and GRN mutations : a genome-wide association study (2018) (0)
- THE EFFECT OF SIRTUIN 3 ON TAU ACETYLATION IN ALZHEIMER'S DISEASE (2018) (0)
- Membrane rafts in the oldest old (2011) (0)
- Type 2 diabetes is associated with increased Alzheimer’s disease neuropathology in ApoE ε 4 Carriers (2014) (0)
- Abstract 10470: Endothelial Dysfunction in Leptomeningeal and Peripheral Arterioles Induced by ß-amyloid Peptides: A Novel Human Model to Study Alzheimer’s Disease (2013) (0)
- STRIATAL AMYLOID VIA [18F]FLUTEMETAMOL PREDICTS CONVERSION FROM AMCI TO PAD (2019) (0)
- LARGE-SCALE PROTEOMIC ANALYSIS OF HUMAN PREFRONTAL CORTEX IDENTIFIES PROTEINS ASSOCIATED WITH COGNITIVE TRAJECTORY IN ADVANCED AGE (2019) (0)
- Clinical Features Predict Lewy Body Pathology and Differentiate between Different Pathologies: A Clinical-Pathologic Prospective Study (P6.231) (2016) (0)
- Whole-Cell Dissociated Suspension Analysis in Human Brain Neurodegenerative Disease: A Pilot Study (2021) (0)
- Longitudinal motor decline in dementia with Lewy bodies and Parkinson’s disease dementia in a community autopsy cohort (2021) (0)
- P2-192: Accumulation of phosphorylated TDP-43 in neurodegenerative disorders (2008) (0)
- Neuropathological Correlates of Visual Hallucinations in Parkinsonism (S03.006) (2013) (0)
- INCREASED ß-APP IN HIPPOCAMPUS AND CORTEX AFTER CHRONIC SYSTEMIC ATROPINE TREATMENT (1996) (0)
- Low diagnostic accuracy for an early clinical diagnosis of Parkinson's Disease (2020) (0)
- Edinburgh Research Explorer In Vivo Distribution of -Synuclein In Multiple Tissues and Biofluids in Parkinson’s Disease (0)
- [18F]T807 ([18F]AV-1451) and Fluorescent Analog T726 Bind to PHF-Tau but Not TDP-43 in Alzheimer’s and FTD Post-Mortem Brain Tissue Sections (2015) (0)
- Restless legs syndrome (RLS) shows increased post-mortem microvascular disease in cortex compared to controls (2019) (0)
- How does diabetes affect plaque and tangle pathology in Alzheimer's Disease? (2011) (0)
- Cognitive Dysfunction, Dementia and Emotional Disturbances (2009) (0)
- Abstract WP416: Comparison of Ex-vivo Human Leptomeningeal Arteriole Function in Cognitively Normal and Dementia Disorders From Rapid Autopsy Brain Donors (2018) (0)
- Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis (2008) (0)
- Neuropathological and biochemical characterization of the oldestold with and without Alzheimer's disease (2011) (0)
- EXCEPTIONALLY LOW RISK OF ALZHEIMER’S DEMENTIA IN APOE2 HOMOZYGOTES (2019) (0)
- Genome-wide association analysis of Dementia with Lewy bodies reveals unique genetic architecture (2017) (0)
- P4-103 Atherosclerosis of cerebral arteries in the pathogenesis of Alzheimer’s disease (2006) (0)
- IDENTIFICATION OF SYNAPTIC TAU ANTIBODIES IN ALZHEIMER'S DISEASE AND RELATED TAUOPATHIES (2018) (0)
- PHOSPHORYLATED TAU AND ALPHA-SYNUCLEIN ACCUMULATION IN FAMILIAL GRANULIN MUTATION CASES (2016) (0)
- Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learning (2020) (0)
- Medin Amyloid, but Not beta-amyloid, Induces Pro-Inflammatory Signaling in Endothelial Cells That is Synergistic With Palmitic Acid (2017) (0)
- Frontal and Hippocampal Tangles and Plaque Density Are Associated with Anosognosia in Alzheimer Disease (P05.051) (2012) (0)
- THE PRESENCE OF NEURONAL PROTEINS IN HUMAN SUBMANDIBULAR GLAND IN ALZHEIMER’S DISEASE AND NONDEMENTED INDIVIDUALS (2018) (0)
- Genes in Stroma Diagnosis of Prostate Cancer Using Differentially Expressed (2011) (0)
- Transcranial Dopplerultrasoundbloodflowvelocityandpulsatilityindex as systemic indicators for Alzheimer's disease (2011) (0)
- PACAP deficit and Cognitive Function in Mild Cognitive Impairment and Alzheimer Dementia (P4.084) (2015) (0)
- Neurodegenerative-related proteins in the evolution of the aging brain (2012) (0)
- TWO DECADES OF RESEARCH USING POSTMORTEM HUMAN MICROGLIA: FINDINGS AND EXPERIENCES FROM BANNER SUN HEALTH RESEARCH INSTITUTE RAPID AUTOPSY PROGRAM (2019) (0)
- S2-04-01 The therapeutic potential of M1 muscarinic agonists in Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) (2004) (0)
- Featured Article Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (0)
- Peripheral Adipose Arteriole Dilator Response to Amyloid Proteins and Palmitic Acid Recapitulates Central Leptomeningeal Arteriole Response: Validation of a Novel Human Tissue Model (2018) (0)
- Reduced CD 59 expression is associated with high membrane attack complex ( MAC ) levels in neurons of Alzheimer ’ s disease (2018) (0)
- Title The influence of Apolipoprotein E genotype on regional pathology in Alzheimer ' s disease (2013) (0)
- Striatal amyloid plaque density predicts braak neurofibrillary tangle stage and clinicopathological Ad: Implications for amyloid imaging (2011) (0)
- Neuropathological diagnoses of subjects autopsied in the phase 3 clinicopathological study of flortaucipir F18 PET imaging (2020) (0)
- The Pituitary Adenylate Cyclase Activating Polypeptide Levels are Associated with Pathological Features of Alzheimer’s Disease (P4.201) (2014) (0)
- The Distribution of Phosphorylated Tau in Spinal Cords of Alzheimer’s and Non-Demented Individuals (2013) (0)
- SINGLE NUCLEI AND SINGLE WHOLE CELL SEQUENCING OF ALZHEIMER’S DISEASE (2019) (0)
- Small rnas in cerebrospinal fluid samples from patients with Alzheimer's disease and neurologically normal controls (2015) (0)
- Does loss of interaction of progranulin and prosaposin promote neurofibrillary tangle development? (2020) (0)
- A neuroanatomical analysis of the distribution of histopathologic lesions in alzheimer's disease (1991) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- Amyloid (cid:1) peptide load is correlated with increased (cid:1) -secretase activity in sporadic Alzheimer’s disease patients (2004) (0)
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005Y2010 (2012) (0)
- Vascular Health and Risk Management Cerebral blood flow in Alzheimer ’ s disease (2012) (0)
- CHARACTERIZATION OF PROGRANULIN EXPRESSION AND LOCALIZATION IN HUMAN BRAIN TISSUES OF AGED, ALZHEIMER’S DISEASE AND FRONTOTEMPORAL DEMENTIA CASES (2019) (0)
- Association Studies of Neuropathologically-Confirmed Cases and Controls Reveals that the PARK10 Locus is a Major Contributor to Sporadic Parkinson disease. (S7.005) (2015) (0)
- Author Response: In Vivo Distribution of α-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease (2021) (0)
- Clinical Features Of Patients With Concomitant Parkinson’s Disease And Progressive Supranuclear Palsy Pathology (P5.247) (2014) (0)
- Abstract 15482: Medin Amyloid Protein-Induced Human Leptomeningeal Arteriole Endothelial Dysfunction and Pro-Inflammatory Signaling are Reversed by Monosialoganglioside Nanoliposomes (2017) (0)
- Robust postmortem correlates of florbetapir-PET beta-amyloid imaging of Alzheimer's disease subjects despite neuropathologic heterogeneity (2012) (0)
- Biochemical characterization of AN1792-immunized Alzheimer's disease individuals (2010) (0)
- RELATIONSHIPS BETWEEN LONGITUDINAL RATES OF LEARNING AND MEMORY DECLINE AND DIFFERENT FORMS OF CEREBROVASCULAR PATHOLOGY IN COGNITIVELY UNIMPAIRED BRAIN DONORS (2019) (0)
- Examination of body mass index, organ weights and diagnosed medical conditions in an autopsy series of nondemented individuals and individuals with Alzheimer's disease (2013) (0)
- Low Diagnostic Accuracy of a Clinical Diagnosis of Early Parkinson’s Disease: Findings of the Arizona Parkinson’s Disease Consortium (S37.001) (2014) (0)
- Neuropathological Validation of the Alzheimer’s Questionnaire (2022) (0)
- 2160 DIAGNOSIS OF PROSTATE CANCER WITHOUT TUMOR CELLS USING DIFFERENTIALLY EXPRESSED GENES IN THE TUMOR MICROENVIRONMENT (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Gerald Beach?
Thomas Gerald Beach is affiliated with the following schools: